“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
Source: https://www.marketwatch.com/story/fda-s ... topstories
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
